{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:57:05Z","timestamp":1790683025632,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Depressive and anxiety symptoms prevalent in major depressive disorder (MDD), that affects millions globally, with many patients showing incomplete response to standard treatments. This open-label pilot study evaluated the effects of a 12-week multi-strain probiotic supplementation on depressive and anxiety symptoms in 30 adults with depressive and anxiety symptoms (e.g., MDD, adjustment disorder, anxiety disorders). Participants received a daily capsule for eight weeks containing 11 bacterial strains (9.8 billion CFU), including\n                    <jats:italic>Bifidobacterium animalis<\/jats:italic>\n                    ssp.\n                    <jats:italic>Lactis Lafti B94<\/jats:italic>\n                    (5 billion CFU) and\n                    <jats:italic>Lactobacillus rhamnosus<\/jats:italic>\n                    RO-11 (1.9 billion CFU). Outcomes were assessed using the Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HAM-A), Generalized Anxiety Disorder 7-item scale (GAD-7), and Clinical Global Impression (CGI) scale at baseline, 4, 8, and 12 weeks following treatment. The intervention was well-tolerated, with minor gastrointestinal side effects in 10% of participants. Significant reductions were observed in HDRS (22.47\u2009\u00b1\u20096.95 to 8.83\u2009\u00b1\u20095.32,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01), HAM-A (32.27\u2009\u00b1\u200911.18 to 13.09\u2009\u00b1\u200910.49,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01), GAD-7 (15.33\u2009\u00b1\u20094.21 to 6.87\u2009\u00b1\u20095.37,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01), and CGI (4.53\u2009\u00b1\u20090.94 to 3.00\u2009\u00b1\u20091.65,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01) scores. Of note, females, participants with tertiary education, and married individuals showed greater improvements. The substantial reductions in these scores suggest probiotics may contribute in the reduction of depressive and anxiety symptoms, potentially via the microbiota-gut-brain axis, supporting further investigation in larger, controlled trials.\n                  <\/jats:p>","DOI":"10.1038\/s41398-026-04334-6","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T10:52:01Z","timestamp":1786013521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-strain probiotic intervention in adults with depressive and anxiety symptoms: A 12-Week pilot study"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9846-1515","authenticated-orcid":false,"given":"Yaniv S.","family":"Ovadia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Okal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dov","family":"Gefel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Shama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pnina","family":"Nir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Pitashny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Amital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"4334_CR1","unstructured":"World Health Organization. Depressive disorder (depression). 2023. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression."},{"key":"4334_CR2","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905\u201317. https:\/\/doi.org\/10.1176\/ajp.2006.163.11.1905.","journal-title":"Am J Psychiatry"},{"key":"4334_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.clinthera.2011.11.024","volume":"34","author":"HD Anderson","year":"2012","unstructured":"Anderson HD, Pace WD, Libby AM, West DR, Valuck RJ. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study. Clin Ther. 2012;34:113\u201323. https:\/\/doi.org\/10.1016\/j.clinthera.2011.11.024.","journal-title":"Clin Ther"},{"key":"4334_CR4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/jamapsychiatry.2021.2573","volume":"78","author":"VL Nikolova","year":"2021","unstructured":"Nikolova VL, Smith MRB, Hall LJ, Cleare AJ, Young AH, Stone JM. Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis. JAMA Psychiatry. 2021;78:1343\u201354. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.2573.","journal-title":"JAMA Psychiatry"},{"key":"4334_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-017-0138-2","volume":"16","author":"CJK Wallace","year":"2017","unstructured":"Wallace CJK, Milev R. The effects of probiotics on depressive symptoms in humans: a systematic review. Ann Gen Psychiatry. 2017;16:14. https:\/\/doi.org\/10.1186\/s12991-017-0138-2.","journal-title":"Ann Gen Psychiatry"},{"key":"4334_CR6","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3390\/nu16071054","volume":"16","author":"A Dziedzic","year":"2024","unstructured":"Dziedzic A, Maciak K, Bli\u017aniewska-Kowalska K, Ga\u0142ecka M, Kobierecka W, Saluk J. The power of psychobiotics in depression: a modern approach through the microbiota-gut-brain axis: a literature review. Nutrients. 2024;16:1054 https:\/\/doi.org\/10.3390\/nu16071054.","journal-title":"Nutrients"},{"key":"4334_CR7","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3390\/cimb44040096","volume":"44","author":"FM Tette","year":"2022","unstructured":"Tette FM, Kwofie SK, Wilson MD. Therapeutic anti-depressant potential of microbial GABA produced by lactobacillus rhamnosus strains for GABAergic signaling restoration and inhibition of addiction-induced HPA axis hyperactivity. Curr Issues Mol Biol. 2022;44:1434\u201351. https:\/\/doi.org\/10.3390\/cimb44040096.","journal-title":"Curr Issues Mol Biol"},{"key":"4334_CR8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/jamapsychiatry.2023.1817","volume":"80","author":"VL Nikolova","year":"2023","unstructured":"Nikolova VL, Cleare AJ, Young AH, Stone JM. Acceptability, tolerability, and estimates of putative treatment effects of probiotics as adjunctive treatment in patients with depression: a randomized clinical trial. JAMA Psychiatry. 2023;80:842\u20137. https:\/\/doi.org\/10.1001\/jamapsychiatry.2023.1817.","journal-title":"JAMA Psychiatry"},{"key":"4334_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jpsychires.2024.11.001","volume":"172","author":"R Moshfeghinia","year":"2025","unstructured":"Moshfeghinia R, Nemati H, Ebrahimi A, Sadeghi A, Khosravi A, Rezaei S. The impact of probiotics, prebiotics, and synbiotics on depression and anxiety symptoms of patients with depression: a systematic review and meta-analysis. J Psychiatr Res. 2025;172:216\u201328. https:\/\/doi.org\/10.1016\/j.jpsychires.2024.11.001.","journal-title":"J Psychiatr Res"},{"key":"4334_CR10","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1176\/appi.ajp.161.12.2163","volume":"161","author":"RM Bagby","year":"2004","unstructured":"Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: Has the gold standard become a lead weight?. Am J Psychiatry. 2004;161:2163\u201377. https:\/\/doi.org\/10.1176\/appi.ajp.161.12.2163.","journal-title":"Am J Psychiatry"},{"key":"4334_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.4088\/JCP.v62n0806","volume":"62","author":"MK Shear","year":"2001","unstructured":"Shear MK, Vander Bilt J, Rucci P, Endicott J, Lydiard B, Otto MW, et al. Reliability and validity of the Hamilton Anxiety Rating Scale in an outpatient sample of anxiety disorder patients. J Clin Psychiatry. 2001;62:616\u201321. https:\/\/doi.org\/10.4088\/JCP.v62n0806.","journal-title":"J Clin Psychiatry"},{"key":"4334_CR12","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 2006;166:1092\u20137. https:\/\/doi.org\/10.1001\/archinte.166.10.1092.","journal-title":"Arch Intern Med"},{"key":"4334_CR13","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD. The Clinical Global Impressions Scale: Applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4:28\u201337. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2880930\/Available from:.","journal-title":"Psychiatry (Edgmont)"},{"key":"4334_CR14","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3390\/ijms19061592","volume":"19","author":"S Liang","year":"2018","unstructured":"Liang S, Wu X, Jin F. Recognizing depression from the microbiota-gut-brain axis. Int J Mol Sci. 2018;19:1592 https:\/\/doi.org\/10.3390\/ijms19061592.","journal-title":"Int J Mol Sci"},{"key":"4334_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.nut.2015.09.015","volume":"32","author":"G Akkasheh","year":"2016","unstructured":"Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M, Jafari P, Akbari H, Taghizadeh M, et al. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition. 2016;32:315\u201320. https:\/\/doi.org\/10.1016\/j.nut.2015.09.015.","journal-title":"Nutrition"},{"key":"4334_CR16","first-page":"45","volume-title":"Mental Health and Social Support","author":"RC Kessler","year":"2013","unstructured":"Kessler RC, Bromet EJ Social support and mental health in community samples. In: Mental Health and Social Support. Springer; 2013. pp. 45\u201360."},{"key":"4334_CR17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/nutrit\/nuae012","volume":"82","author":"A Asad","year":"2024","unstructured":"Asad A, Kirk M, Zhu S, Dong X, Gao M. Effects of prebiotics and probiotics on symptoms of depression and anxiety in clinically diagnosed samples: systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2024;82:614\u201325. https:\/\/doi.org\/10.1093\/nutrit\/nuae012.","journal-title":"Nutr Rev"},{"key":"4334_CR18","doi-asserted-by":"publisher","first-page":"8292","DOI":"10.1080\/10408398.2022.2051164","volume":"63","author":"V Musazadeh","year":"2023","unstructured":"Musazadeh V, Zarezadeh M, Faghfouri AH, Keramati M, Ghadiri M, Farzin L, et al. Probiotics as an effective therapeutic approach in alleviating depression symptoms: an umbrella meta-analysis. Crit Rev Food Sci Nutr. 2023;63:8292\u20138300. https:\/\/doi.org\/10.1080\/10408398.2022.2051164.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4334_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.112568","volume":"282","author":"KK Goh","year":"2019","unstructured":"Goh KK, Liu YW, Kuo PH, Chung YE, Lu ML, Chen CH. Effect of probiotics on depressive symptoms: a meta-analysis of human studies. Psychiatry Res. 2019;282:112568. https:\/\/doi.org\/10.1016\/j.psychres.2019.112568.","journal-title":"Psychiatry Res"},{"key":"4334_CR20","doi-asserted-by":"publisher","first-page":"105561","DOI":"10.1016\/j.neubiorev.2023.105561","volume":"158","author":"C Ribera","year":"2024","unstructured":"Ribera C, S\u00e1nchez-Ort\u00ed JV, Clarke G, Marx W, M\u00f6rkl S, Balanz\u00e1-Mart\u00ednez V. Probiotic, prebiotic, synbiotic and fermented food supplementation in psychiatric disorders: a systematic review of clinical trials. Neurosci Biobehav Rev. 2024;158:105561 https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105561.","journal-title":"Neurosci Biobehav Rev"},{"key":"4334_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01994-z","volume":"12","author":"AC Schaub","year":"2022","unstructured":"Schaub AC, Schneider E, Vazquez-Castellanos JF, Schweinfurth N, Kettelhack C, Doll JPK, et al. Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial. Transl Psychiatry. 2022;12:227. https:\/\/doi.org\/10.1038\/s41398-022-01994-z.","journal-title":"Transl Psychiatry"},{"key":"4334_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-026-03900-2","volume":"16","author":"D Zilles-Wegner","year":"2026","unstructured":"Zilles-Wegner D, von M\u00fccke-Heim IA, Yrondi A, Takamiya A. Clinical and biological markers of electroconvulsive therapy effectiveness: a narrative review. Transl Psychiatry. 2026;16:87. https:\/\/doi.org\/10.1038\/s41398-026-03900-2.","journal-title":"Transl Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04334-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04334-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04334-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:04:49Z","timestamp":1790679889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04334-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4334"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04334-6","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"497"}}